Telemetry Investments’s Mustang Bio MBIO Stock Holding History

Telemetry Investments’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$155K	Sell	524 -79	-13%	-$27K	0.24%	79
2022 Q3	$212K	Buy	603 +23	+4%	+$10.7K	0.27%	95
2022 Q2	$254K	Buy	580 +183	+46%	+$101K	0.3%	90
2022 Q1	$300K	Buy	397 +170	+75%	+$140K	0.47%	75
2021 Q4	$282K	Buy	227 +60	+36%	+$96.9K	0.36%	95
2021 Q3	$336K	Buy	+167	New	+$359K	0.45%	75
2021 Q1	–	Sell	-199	Closed	-$564K	–	136
2020 Q4	$564K	Sell	199 -100	-33%	-$239K	0.95%	43
2020 Q3	$706K	Sell	299 -7	-2%	-$17.3K	1.53%	28
2020 Q2	$729K	Buy	306 +230	+303%	+$538K	1.98%	22
2020 Q1	$152K	Buy	+76	New	+$195K	0.53%	43

Other funds holding MBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Telemetry Investments's MBIO Position: Q4 2022 in Review

Telemetry Investments reduced its Mustang Bio (MBIO) stake by 13% in Q4 2022, selling an estimated $27K and leaving 524 shares worth $155K. The position accounts for 0.24% of the portfolio, ranked #79.

Telemetry Investments first reported a position in MBIO in Q1 2020 and has held it in 10 quarters since. The position peaked at $729K in Q2 2020. 60 funds tracked by Wall St. Rank hold MBIO as of Q4 2022.

Telemetry Investments held 524 shares of Mustang Bio worth $155K as of Q4 2022.
Telemetry Investments sold 79 Mustang Bio shares in Q4 2022, an estimated $27K.
Mustang Bio made up 0.24% of Telemetry Investments's portfolio in Q4 2022, its #79 holding.
Telemetry Investments first reported a position in Mustang Bio in Q1 2020 and has held it in 10 quarters since.
Telemetry Investments's Mustang Bio position peaked at $729K in Q2 2020.
60 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.